Latest Sulfoxides Stories
SOUTH SAN FRANCISCO, June 30, 2014 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today
DUBLIN, May 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Cephalon, Inc.
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/lj5htc/investigation) has announced the addition of the
Sample-to-result system has FDA 510(k) clearance and provides CYP2C19 test results in 60 minutes. Ottawa, Ontario (PRWEB) November 19, 2013 Spartan Bioscience
- A volcanic mudflow.